We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Sami Viskin

Sami Viskin MD

Associate Professor; Director, Cardiac hospitalization, Department of Cardiology, Tel Aviv Medical Center, Sackler School of Medicine, Tel Aviv University, Israel.

Recent Contributions to PracticeUpdate:

  1. Efficacy and Limitations of Quinidine in Patients With Brugada Syndrome
  2. Challenge and Impact of Quinidine Access in Sudden Death Syndromes
  3. Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome
  4. Programmed Ventricular Stimulation for Brugada Syndrome Risk Stratification
  5. Early Repolarization Pattern Defined

Most Read This Week

Recently Updated